CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tacrolimus hydrate
Accession: CHEBI:61057
browse the term
Definition: A hydrate that is the monohydrate form of tacrolimus.
Synonyms: exact_synonym: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone--water (1/1)
related_synonym: (-)-(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone monohydrate; Formula=C44H71NO13; InChI=1S/C44H69NO12.H2O/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7;/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3;1H2/b25-19+,27-21+;/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+;/m0./s1; InChIKey=NWJQLQGQZSIBAF-MLAUYUEBSA-N; Prograf; Protopic; SMILES=O.CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H]([C@H](C[C@@H](C)C\\C(C)=C\\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC)[C@H](C[C@H]2C)OC; tacrolimus; tacrolimus monohydrate; tsukubaenolide hydrate
xref: CAS:109581-93-3; DrugBank:DB00864; KEGG:D00107
xref_mesh: MESH:D016559
xref: Reaxys:6265275
G
A2m
alpha-2-macroglobulin
increases expression
EXP
Tacrolimus results in increased expression of A2M mRNA
CTD
PMID:21865292
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions increases expression
ISO EXP
[Sirolimus co-treated with Tacrolimus] results in increased expression of ABCA1 protein Tacrolimus results in increased expression of ABCA1 mRNA
CTD
PMID:17016853 PMID:21865292
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Tacrolimus results in decreased activity of ABCB11 protein
CTD
PMID:23956101
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects export affects response to substance increases export increases response to substance multiple interactions decreases activity
ISO
ABCB1 protein affects the export of Tacrolimus ABCB1 protein affects the susceptibility to Tacrolimus ABCB1 protein results in increased export of Tacrolimus ABCB1 gene SNP results in increased susceptibility to Tacrolimus [Tacrolimus binds to ABCB1 protein] inhibits the reaction [azidoprazosin binds to ABCB1 protein]; [Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]
CTD
PMID:1381629 PMID:11920757 PMID:12352921 PMID:15919446 PMID:15964336 PMID:20080907 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acaa1b
acetyl-Coenzyme A acyltransferase 1B
decreases expression
ISO
Tacrolimus results in decreased expression of ACAA1B mRNA
CTD
PMID:25270620
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
G
Acadl
acyl-CoA dehydrogenase, long chain
decreases expression
ISO
Tacrolimus results in decreased expression of ACADL mRNA
CTD
PMID:25270620
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
G
Ace2
angiotensin converting enzyme 2
decreases expression
EXP
Tacrolimus results in decreased expression of ACE2 mRNA
CTD
PMID:21865292
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]
CTD
PMID:15207740
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Acta2
actin alpha 2, smooth muscle
increases expression
ISO
Tacrolimus results in increased expression of ACTA2 protein
CTD
PMID:29362864
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Acvr1b
activin A receptor type 1B
multiple interactions
ISO
[Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]
CTD
PMID:16720724
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
increases expression
EXP
Tacrolimus results in increased expression of ADAMTS1 mRNA
CTD
PMID:21865292
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
increases expression
ISO
Tacrolimus results in increased expression of ADAMTS2 mRNA
CTD
PMID:29362864
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
G
Adcy9
adenylate cyclase 9
multiple interactions
ISO
Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]
CTD
PMID:30607468
NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
G
Adra1d
adrenoceptor alpha 1D
increases expression
EXP
Tacrolimus results in increased expression of ADRA1D mRNA
CTD
PMID:21865292
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Aif1
allograft inflammatory factor 1
increases expression
ISO
Tacrolimus results in increased expression of AIF1 mRNA
CTD
PMID:29362864
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
ISO
Tacrolimus results in decreased expression of ALDH1A1 mRNA
CTD
PMID:25270620
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh2
aldehyde dehydrogenase 2 family member
decreases expression
ISO
Tacrolimus results in decreased expression of ALDH2 mRNA
CTD
PMID:25270620
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh9a1
aldehyde dehydrogenase 9 family, member A1
decreases expression
ISO
Tacrolimus results in decreased expression of ALDH9A1 mRNA
CTD
PMID:25270620
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
G
Alg3
ALG3, alpha-1,3- mannosyltransferase
decreases expression
ISO
Tacrolimus results in decreased expression of ALG3 mRNA
CTD
PMID:25270620
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
G
Angptl6
angiopoietin-like 6
increases expression
EXP
Tacrolimus results in increased expression of ANGPTL6 mRNA
CTD
PMID:21865292
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
G
Ankrd1
ankyrin repeat domain 1
increases expression
ISO
Tacrolimus results in increased expression of ANKRD1 mRNA
CTD
PMID:29362864
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Ankrd34a
ankyrin repeat domain 34A
decreases expression
ISO
Tacrolimus results in decreased expression of ANKRD34A mRNA
CTD
PMID:25270620
NCBI chr 2:184,129,830...184,135,075
Ensembl chr 2:184,129,238...184,135,116
G
Anpep
alanyl aminopeptidase, membrane
increases secretion
EXP
Tacrolimus results in increased secretion of ANPEP protein
CTD
PMID:7514309
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Anxa1
annexin A1
increases expression
EXP
Tacrolimus results in increased expression of ANXA1
CTD
PMID:20484890
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Aoc1
amine oxidase, copper containing 1
increases expression
ISO
Tacrolimus results in increased expression of AOC1 mRNA
CTD
PMID:29362864
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
G
Areg
amphiregulin
increases expression
EXP
Tacrolimus results in increased expression of AREG mRNA
CTD
PMID:21865292
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arfrp1
ADP-ribosylation factor related protein 1
increases expression
ISO
Tacrolimus results in increased expression of ARFRP1 mRNA
CTD
PMID:25270620
NCBI chr 3:168,466,351...168,473,960
Ensembl chr 3:168,466,496...168,473,914
G
Arhgap45
Rho GTPase activating protein 45
increases expression
ISO
Tacrolimus results in increased expression of ARHGAP45 mRNA
CTD
PMID:21621594
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
G
Arhgef11
Rho guanine nucleotide exchange factor 11
increases expression
ISO
Tacrolimus results in increased expression of ARHGEF11 mRNA
CTD
PMID:29380240
NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
G
Arpc5
actin related protein 2/3 complex, subunit 5
increases expression
ISO
Tacrolimus results in increased expression of ARPC5 mRNA
CTD
PMID:29380240
NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
G
Arv1
ARV1 homolog, fatty acid homeostasis modulator
increases expression
ISO
Tacrolimus results in increased expression of ARV1 mRNA
CTD
PMID:25270620
NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
G
Asxl3
ASXL transcriptional regulator 3
decreases expression
ISO
Tacrolimus results in decreased expression of ASXL3 mRNA
CTD
PMID:29362864
NCBI chr18:13,593,529...13,766,324
Ensembl chr18:13,593,985...13,762,427
G
Atf3
activating transcription factor 3
increases expression
ISO
Tacrolimus results in increased expression of ATF3 mRNA
CTD
PMID:23958496
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression
ISO
Tacrolimus results in increased expression of ATF4 mRNA
CTD
PMID:23958496
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf6
activating transcription factor 6
increases expression
ISO
Tacrolimus results in increased expression of ATF6 mRNA
CTD
PMID:23958496
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
decreases expression
ISO
Tacrolimus results in decreased expression of ATP1B1 mRNA
CTD
PMID:25270620
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp1b3
ATPase Na+/K+ transporting subunit beta 3
decreases expression
ISO
Tacrolimus results in decreased expression of ATP1B3 mRNA
CTD
PMID:25270620
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
increases expression
ISO
Tacrolimus results in increased expression of ATP2A2 mRNA
CTD
PMID:25270620
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
B2m
beta-2 microglobulin
increases expression
ISO
Tacrolimus results in increased expression of B2M mRNA
CTD
PMID:29362864
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
Bad
BCL2-associated agonist of cell death
multiple interactions
EXP ISO
Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein] Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein]
CTD
PMID:15036616 PMID:15280438
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Batf3
basic leucine zipper ATF-like transcription factor 3
increases expression
ISO
Tacrolimus results in increased expression of BATF3 mRNA
CTD
PMID:29362864
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein] [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein Tacrolimus results in increased expression of BAX protein
CTD
PMID:10205001 PMID:15571979 PMID:27606422 PMID:35033536
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression decreases expression
ISO EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein] Tacrolimus results in increased expression of BCL2 protein [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein Tacrolimus results in decreased expression of BCL2 protein
CTD
PMID:10205001 PMID:15571979 PMID:27606422
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein]
CTD
PMID:10532544
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl3
BCL3, transcription coactivator
increases expression
ISO
Tacrolimus results in increased expression of BCL3 mRNA
CTD
PMID:23958496
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
EXP
Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]; Tacrolimus promotes the reaction [U 0126 inhibits the reaction [decamethrin results in increased expression of BDNF exon]]; U 0126 promotes the reaction [Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]]
CTD
PMID:22079160
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
EXP
Tacrolimus results in increased expression of BIRC3 mRNA
CTD
PMID:21865292
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
Tacrolimus results in decreased expression of BIRC5 mRNA
CTD
PMID:16574167
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bmp7
bone morphogenetic protein 7
multiple interactions decreases expression
EXP
Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]; valsartan inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]
CTD
PMID:17703430
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
Tacrolimus results in increased expression of BTG2 mRNA
CTD
PMID:21865292
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btnl9
butyrophilin-like 9
decreases expression
ISO
Tacrolimus results in decreased expression of BTNL9 mRNA
CTD
PMID:29362864
NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
G
C1qa
complement C1q A chain
increases expression
ISO
Tacrolimus results in increased expression of C1QA mRNA
CTD
PMID:29362864
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
increases expression
ISO
Tacrolimus results in increased expression of C1QB mRNA
CTD
PMID:29362864
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C1qc
complement C1q C chain
increases expression
ISO
Tacrolimus results in increased expression of C1QC mRNA
CTD
PMID:29362864
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
C2
complement C2
increases expression
EXP
Tacrolimus results in increased expression of C2 mRNA
CTD
PMID:21865292
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
C3
complement C3
increases expression
EXP ISO
Tacrolimus results in increased expression of C3 mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4b
complement C4B
increases expression
EXP
Tacrolimus results in increased expression of C4B mRNA
CTD
PMID:21865292
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
Calb1
calbindin 1
decreases expression
EXP
Tacrolimus results in decreased expression of CALB1 mRNA; Tacrolimus results in decreased expression of CALB1 protein
CTD
PMID:14978156 PMID:21865292
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Calcr
calcitonin receptor
multiple interactions
ISO
Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]
CTD
PMID:21869564
NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392
G
Calr
calreticulin
increases expression
ISO
Tacrolimus results in increased expression of CALR mRNA
CTD
PMID:25270620
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
increases expression
ISO
Tacrolimus results in increased expression of CAMK1D mRNA
CTD
PMID:23958496
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
G
Capg
capping actin protein, gelsolin like
increases expression
EXP
Tacrolimus results in increased expression of CAPG mRNA
CTD
PMID:21865292
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein] Tacrolimus results in increased activity of CASP3 protein Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein] MK0626 inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein] Tacrolimus results in increased cleavage of CASP3 protein
CTD
PMID:10205001 PMID:12642403 PMID:12871656 PMID:12892836 PMID:15207740 PMID:15548389 PMID:15571979 PMID:17166486 PMID:17385075 PMID:20149694 PMID:24959755 PMID:27606422 PMID:35033536 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases expression
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein] Tacrolimus results in increased expression of CASP8 protein
CTD
PMID:15548389 PMID:27606422
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases expression
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] Tacrolimus results in increased expression of CASP9 protein
CTD
PMID:15548389 PMID:27606422
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases expression decreases response to substance
EXP ISO
Tacrolimus results in increased expression of CAT protein CAT protein results in decreased susceptibility to Tacrolimus
CTD
PMID:14675044 PMID:18766458
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbll1
Cbl proto-oncogene like 1
increases expression
ISO
Tacrolimus results in increased expression of CBLL1 mRNA
CTD
PMID:21621594
NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:48,071,190...48,086,444
G
Ccdc88b
coiled-coil domain containing 88B
increases expression
ISO
Tacrolimus results in increased expression of CCDC88B mRNA
CTD
PMID:29362864
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
G
Ccl11
C-C motif chemokine ligand 11
decreases expression
ISO
Tacrolimus results in decreased expression of CCL11 mRNA
CTD
PMID:15948978
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
increases expression
ISO
Tacrolimus results in increased expression of CCL17 mRNA
CTD
PMID:29362864
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
EXP ISO
pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD
PMID:12472797 PMID:23958496 PMID:29362864 PMID:36416909
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Tacrolimus results in increased expression of CCL20 mRNA
CTD
PMID:23958496
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]
CTD
PMID:36416909
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
decreases expression multiple interactions increases expression
ISO
Tacrolimus results in decreased expression of CCL5 mRNA 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD
PMID:15948978 PMID:23958496 PMID:25270620
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
increases expression
ISO
Tacrolimus results in increased expression of CCL7 mRNA
CTD
PMID:23958496 PMID:29362864
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccl9
C-C motif chemokine ligand 9
increases expression
EXP ISO
Tacrolimus results in increased expression of CCL6 mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccn2
cellular communication network factor 2
multiple interactions
EXP
Tacrolimus inhibits the reaction [Paraquat results in increased expression of CCN2 mRNA]; Tacrolimus inhibits the reaction [Paraquat results in increased secretion of CCN2 protein]
CTD
PMID:33000210
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
increases expression
ISO
Tacrolimus results in increased expression of CCNA2 mRNA
CTD
PMID:29362864
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb2
cyclin B2
decreases expression increases expression
ISO
Tacrolimus results in decreased expression of CCNB2 mRNA Tacrolimus results in increased expression of CCNB2 mRNA
CTD
PMID:16574167 PMID:29362864
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccr2
C-C motif chemokine receptor 2
increases expression
ISO
Tacrolimus results in increased expression of CCR2 mRNA
CTD
PMID:29362864
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
decreases expression
ISO
Tacrolimus results in decreased expression of CCR3 mRNA
CTD
PMID:15948978
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccrl2
C-C motif chemokine receptor like 2
increases expression
ISO
Tacrolimus results in increased expression of CCRL2 mRNA
CTD
PMID:23958496
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
G
Cd2
Cd2 molecule
multiple interactions
ISO
Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]
CTD
PMID:1705513
NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026
G
Cd44
CD44 molecule
increases expression
EXP
Tacrolimus results in increased expression of CD44 mRNA
CTD
PMID:21865292
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd68
Cd68 molecule
increases expression
EXP
Tacrolimus results in increased expression of CD68 mRNA
CTD
PMID:21865292
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd74
CD74 molecule
increases expression
ISO
Tacrolimus results in increased expression of CD74 mRNA
CTD
PMID:23958496
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd80
Cd80 molecule
decreases expression
ISO
Tacrolimus results in decreased expression of CD80 protein
CTD
PMID:15241357
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
increases expression
ISO
Tacrolimus results in increased expression of CD83 mRNA
CTD
PMID:29362864
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd86
CD86 molecule
decreases expression
ISO
Tacrolimus results in decreased expression of CD86 protein
CTD
PMID:15241357
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdca3
cell division cycle associated 3
increases expression
ISO
Tacrolimus results in increased expression of CDCA3 mRNA
CTD
PMID:29362864
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca5
cell division cycle associated 5
increases expression
ISO
Tacrolimus results in increased expression of CDCA5 mRNA
CTD
PMID:29362864
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
G
Cdca8
cell division cycle associated 8
increases expression
ISO
Tacrolimus results in increased expression of CDCA8 mRNA
CTD
PMID:29362864
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdh1
cadherin 1
decreases expression
ISO
Tacrolimus results in decreased expression of CDH1 protein
CTD
PMID:22416070
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh11
cadherin 11
increases expression
ISO
Tacrolimus results in increased expression of CDH11 mRNA
CTD
PMID:29362864
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdh16
cadherin 16
decreases expression
ISO
Tacrolimus results in decreased expression of CDH16 mRNA
CTD
PMID:22416070
NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
EXP
Tacrolimus results in increased expression of CDKN1B mRNA
CTD
PMID:21865292
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
Tacrolimus results in increased expression of CEBPA mRNA
CTD
PMID:29362864
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cenpw
centromere protein W
increases expression
ISO
Tacrolimus results in increased expression of CENPW mRNA
CTD
PMID:29362864
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
G
Cfi
complement factor I
increases expression
EXP
Tacrolimus results in increased expression of CFI mRNA
CTD
PMID:21865292
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Ckap2
cytoskeleton associated protein 2
increases expression
ISO
Tacrolimus results in increased expression of CKAP2 mRNA
CTD
PMID:29362864
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Ckap4
cytoskeleton-associated protein 4
increases expression
EXP
Tacrolimus results in increased expression of CKAP4 mRNA
CTD
PMID:21865292
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Cldn1
claudin 1
decreases expression
ISO
Tacrolimus results in decreased expression of CLDN1 mRNA
CTD
PMID:22416070
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn4
claudin 4
increases expression
EXP
Tacrolimus results in increased expression of CLDN4 mRNA
CTD
PMID:21865292
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Cldn7
claudin 7
increases expression
EXP
Tacrolimus results in increased expression of CLDN7 mRNA
CTD
PMID:21865292
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Clec7a
C-type lectin domain containing 7A
increases expression
ISO
Tacrolimus results in increased expression of CLEC7A mRNA
CTD
PMID:29362864
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Clk3
CDC-like kinase 3
increases expression
ISO
Tacrolimus results in increased expression of CLK3 mRNA
CTD
PMID:25270620
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
G
Clu
clusterin
increases expression
EXP
Tacrolimus results in increased expression of CLU mRNA
CTD
PMID:21865292
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Coch
cochlin
increases expression
ISO
Tacrolimus results in increased expression of COCH mRNA
CTD
PMID:25270620
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Tacrolimus results in increased expression of COL1A1 mRNA
CTD
PMID:29362864
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
increases expression
ISO
Tacrolimus results in increased expression of COL1A2 mRNA
CTD
PMID:29362864
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
increases expression
ISO
Tacrolimus results in increased expression of COL3A1 mRNA
CTD
PMID:29362864
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Cops8
COP9 signalosome subunit 8
increases expression
ISO
Tacrolimus results in increased expression of COPS8 mRNA
CTD
PMID:25270620
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
G
Cp
ceruloplasmin
increases expression
EXP
Tacrolimus results in increased expression of CP mRNA
CTD
PMID:21865292
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Creb3l3
cAMP responsive element binding protein 3-like 3
decreases expression
ISO
Tacrolimus results in decreased expression of CREB3L3 mRNA
CTD
PMID:25270620
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Creld2
cysteine-rich with EGF-like domains 2
increases expression
ISO
Tacrolimus results in increased expression of CRELD2 mRNA
CTD
PMID:25270620
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
G
Csf1
colony stimulating factor 1
increases expression
ISO
Tacrolimus results in increased expression of CSF1 mRNA
CTD
PMID:23958496
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf2
colony stimulating factor 2
decreases expression multiple interactions increases expression
ISO
Tacrolimus results in decreased expression of CSF2 protein Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] Tacrolimus results in increased expression of CSF2 mRNA
CTD
PMID:1376361 PMID:11407316 PMID:23958496
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
increases expression
ISO
Tacrolimus results in increased expression of CSF2RB2 mRNA
CTD
PMID:29362864
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
G
Ctsl
cathepsin L
multiple interactions increases expression
ISO EXP
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSL protein] Tacrolimus results in increased expression of CTSL mRNA
CTD
PMID:18172886 PMID:21865292 PMID:25270620
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
EXP ISO
Tacrolimus results in increased expression of CXCL10 mRNA
CTD
PMID:21865292 PMID:23958496 PMID:25270620
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
ISO
Tacrolimus results in increased expression of CXCL11 mRNA
CTD
PMID:23958496
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cyba
cytochrome b-245 alpha chain
multiple interactions increases expression
ISO
Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA]
CTD
PMID:12352326
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
increases expression
EXP
Tacrolimus results in increased expression of CYP27B1 mRNA
CTD
PMID:21865292
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
CYP2C19 affects the reaction [Lansoprazole affects the susceptibility to Tacrolimus]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP2C19 gene mutant form affects the susceptibility to [Lansoprazole co-treated with Tacrolimus]
CTD
PMID:15010519 PMID:15285851 PMID:17377957
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing multiple interactions decreases methylation affects metabolic processing
ISO
CYP3A4 protein results in increased metabolism of Tacrolimus Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus] CYP3A4 protein results in decreased methylation of Tacrolimus CYP3A4 protein affects the metabolism of Tacrolimus
CTD
PMID:15010519 PMID:15855244 PMID:15919446 PMID:15951320 PMID:15964336
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions affects response to substance affects metabolic processing decreases methylation
ISO
CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus] CYP3A5 gene affects the susceptibility to Tacrolimus; CYP3A5 polymorphism affects the susceptibility to Tacrolimus CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus CYP3A5 protein results in decreased methylation of Tacrolimus
CTD
PMID:15502717 PMID:15723604 PMID:15729180 PMID:15808586 PMID:15919447 PMID:15951320 PMID:15964336 PMID:17377957 PMID:19384264 PMID:36931438 More...
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dcn
decorin
increases expression
ISO
Tacrolimus results in increased expression of DCN mRNA
CTD
PMID:29362864
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein] Tacrolimus results in increased expression of DDIT3 mRNA
CTD
PMID:23958496 PMID:25270620
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4l
DNA-damage-inducible transcript 4-like
decreases expression
EXP
Tacrolimus results in decreased expression of DDIT4L mRNA
CTD
PMID:21865292
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Tacrolimus results in decreased expression of DHCR24 mRNA
CTD
PMID:25270620
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dnajc30
DnaJ heat shock protein family (Hsp40) member C30
decreases expression
ISO
Tacrolimus results in decreased expression of DNAJC30 mRNA
CTD
PMID:25270620
NCBI chr12:21,628,319...21,629,398
Ensembl chr12:21,626,450...21,629,408
G
Dnm1l
dynamin 1-like
multiple interactions
ISO
PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein] Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein]
CTD
PMID:19492085 PMID:26318285
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Doc2a
double C2 domain alpha
decreases expression
ISO
Tacrolimus results in decreased expression of DOC2A mRNA
CTD
PMID:25270620
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
G
Dock10
dedicator of cytokinesis 10
increases expression
ISO
Tacrolimus results in increased expression of DOCK10 mRNA
CTD
PMID:29362864
NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
G
Dpp4
dipeptidylpeptidase 4
increases activity multiple interactions
EXP
Tacrolimus results in increased activity of DPP4 protein MK0626 inhibits the reaction [Tacrolimus results in increased activity of DPP4 protein]
CTD
PMID:24959755
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Drd2
dopamine receptor D2
affects activity multiple interactions
EXP
Tacrolimus affects the activity of DRD2 protein Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD
PMID:15332494
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Ech1
enoyl-CoA hydratase 1
decreases expression
ISO
Tacrolimus results in decreased expression of ECH1 mRNA
CTD
PMID:25270620
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
ISO
Tacrolimus results in increased expression of EDEM1 mRNA
CTD
PMID:25270620
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Edn1
endothelin 1
increases expression
EXP
Tacrolimus results in increased expression of EDN1 mRNA; Tacrolimus results in increased expression of EDN1 protein
CTD
PMID:9517403 PMID:9931093
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Ednra
endothelin receptor type A
increases activity increases expression
EXP
Tacrolimus results in increased activity of EDNRA protein Tacrolimus results in increased expression of EDNRA mRNA
CTD
PMID:8587392 PMID:15964565
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
increases expression
ISO
Tacrolimus results in increased expression of EFEMP2 mRNA
CTD
PMID:29362864
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
G
Egr1
early growth response 1
increases expression
EXP
Tacrolimus results in increased expression of EGR1 mRNA
CTD
PMID:21865292
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
increases expression
EXP
Tacrolimus results in increased expression of EGR2 mRNA
CTD
PMID:21865292
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
Tacrolimus inhibits the reaction [Sirolimus results in decreased phosphorylation of and results in increased activity of EIF4EBP1 protein]
CTD
PMID:8599949
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elac2
elaC ribonuclease Z 2
decreases expression
ISO
Tacrolimus results in decreased expression of ELAC2 mRNA
CTD
PMID:25270620
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of ERN1 protein
CTD
PMID:23958496
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
Tacrolimus results in increased expression of ERO1A mRNA
CTD
PMID:23958496
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Exosc4
exosome component 4
decreases expression
ISO
Tacrolimus results in decreased expression of EXOSC4 mRNA
CTD
PMID:25270620
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
Tacrolimus results in decreased expression of F2R mRNA
CTD
PMID:25270620
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
Fabp2
fatty acid binding protein 2
decreases expression
ISO
Tacrolimus results in decreased expression of FABP2 mRNA
CTD
PMID:25270620
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein]
CTD
PMID:15548389
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
decreases secretion
ISO
Tacrolimus results in decreased secretion of FASLG protein
CTD
PMID:11692113
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbln1
fibulin 1
increases expression
EXP
Tacrolimus results in increased expression of FBLN1 mRNA
CTD
PMID:21865292
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fga
fibrinogen alpha chain
increases expression
EXP
Tacrolimus results in increased expression of FGA mRNA
CTD
PMID:21865292
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
increases expression
EXP
Tacrolimus results in increased expression of FGB mRNA
CTD
PMID:21865292
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgd2
FYVE, RhoGEF and PH domain containing 2
increases expression
ISO
Tacrolimus results in increased expression of FGD2 mRNA
CTD
PMID:29362864
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
G
Fgf21
fibroblast growth factor 21
decreases expression
ISO
Tacrolimus results in decreased expression of FGF21 mRNA
CTD
PMID:25270620
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Fgl2
fibrinogen-like 2
increases expression
EXP ISO
Tacrolimus results in increased expression of FGL2 mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
Tacrolimus results in increased expression of FHL2 mRNA
CTD
PMID:29362864
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fkbp1a
FKBP prolyl isomerase 1A
multiple interactions increases expression
ISO EXP
[Tacrolimus binds to FKBP1A protein] inhibits the reaction [Sirolimus binds to FKBP1A protein]; [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]] Tacrolimus results in increased expression of FKBP1A protein
CTD
PMID:10361256 PMID:11041285 PMID:16720724
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Fkbp5
FKBP prolyl isomerase 5
multiple interactions
ISO
Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein]
CTD
PMID:15697228
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Flt3
Fms related receptor tyrosine kinase 3
increases expression
ISO
Tacrolimus results in increased expression of FLT3 mRNA
CTD
PMID:29362864
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fmo2
flavin containing dimethylaniline monoxygenase 2
increases expression
ISO
Tacrolimus results in increased expression of FMO2 mRNA
CTD
PMID:21621594
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
G
Fn1
fibronectin 1
multiple interactions increases expression
ISO
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA] Tacrolimus results in increased expression of FN1 mRNA
CTD
PMID:15939815 PMID:29362864
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fndc3a
fibronectin type III domain containing 3a
increases expression
ISO
Tacrolimus results in increased expression of FNDC3A mRNA
CTD
PMID:25270620
NCBI chr15:47,689,909...47,867,354
Ensembl chr15:47,689,919...47,866,784
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tacrolimus results in increased expression of FOS mRNA
CTD
PMID:23958496
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Tacrolimus results in increased expression of FOSL1 mRNA
CTD
PMID:23958496
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Gbp1
guanylate binding protein 1
decreases expression
ISO
Tacrolimus results in decreased expression of GBP1 mRNA
CTD
PMID:21621594
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gc
GC, vitamin D binding protein
decreases expression increases expression
EXP ISO
Tacrolimus results in decreased expression of GC mRNA Tacrolimus results in increased expression of GC mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gcg
glucagon
multiple interactions decreases secretion
EXP
MK0626 inhibits the reaction [Tacrolimus results in decreased secretion of GCG protein modified form]
CTD
PMID:24959755
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Gins2
GINS complex subunit 2
increases expression
ISO
Tacrolimus results in increased expression of GINS2 mRNA
CTD
PMID:29362864
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gjb1
gap junction protein, beta 1
increases expression
ISO
Tacrolimus results in increased expression of GJB1 mRNA
CTD
PMID:21621594
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gldc
glycine decarboxylase
decreases expression
ISO
Tacrolimus results in decreased expression of GLDC mRNA
CTD
PMID:25270620
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Glp1r
glucagon-like peptide 1 receptor
decreases expression multiple interactions
EXP
Tacrolimus results in decreased expression of GLP1R protein MK0626 inhibits the reaction [Tacrolimus results in decreased expression of GLP1R protein]
CTD
PMID:24959755
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
G
Gpihbp1
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
decreases expression
ISO
Tacrolimus results in decreased expression of GPIHBP1 mRNA
CTD
PMID:29362864
NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702
G
Gpn2
GPN-loop GTPase 2
increases expression
ISO
Tacrolimus results in increased expression of GPN2 mRNA
CTD
PMID:25270620
NCBI chr 5:145,809,455...145,817,252
Ensembl chr 5:145,809,651...145,817,252
G
Gpnmb
glycoprotein nmb
increases expression
EXP
Tacrolimus results in increased expression of GPNMB mRNA
CTD
PMID:21865292
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Grn
granulin precursor
increases expression
ISO
Tacrolimus results in increased expression of GRN mRNA
CTD
PMID:25270620
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsk3a
glycogen synthase kinase 3 alpha
multiple interactions increases phosphorylation
ISO
[GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein] Tacrolimus results in increased phosphorylation of GSK3A protein
CTD
PMID:22416070
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions increases phosphorylation
ISO
[GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein] Tacrolimus results in increased phosphorylation of GSK3B protein
CTD
PMID:22416070
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gtpbp4
GTP binding protein 4
decreases expression
EXP
Tacrolimus results in decreased expression of GTPBP4 mRNA
CTD
PMID:21865292
NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
G
Guca2a
guanylate cyclase activator 2A
increases expression
EXP
Tacrolimus results in increased expression of GUCA2A mRNA
CTD
PMID:21865292
NCBI chr 5:133,237,177...133,239,019
Ensembl chr 5:133,237,177...133,239,018
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
ISO
Tacrolimus results in decreased expression of HADHB mRNA
CTD
PMID:25270620
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
EXP
Tacrolimus results in increased expression of HAVCR1 mRNA
CTD
PMID:21865292
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Tacrolimus results in increased expression of HERPUD1 mRNA
CTD
PMID:23958496 PMID:25270620
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hexa
hexosaminidase subunit alpha
increases expression
ISO
Tacrolimus results in increased expression of HEXA mRNA
CTD
PMID:25270620
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hgs
hepatocyte growth factor-regulated tyrosine kinase substrate
increases expression
ISO
Tacrolimus results in increased expression of HGS mRNA
CTD
PMID:29380240
NCBI chr10:105,739,617...105,757,838
Ensembl chr10:105,739,296...105,757,835
G
Hk2
hexokinase 2
increases expression
ISO
Tacrolimus results in increased expression of HK2 mRNA
CTD
PMID:29362864
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Hk3
hexokinase 3
increases expression
ISO
Tacrolimus results in increased expression of HK3 mRNA
CTD
PMID:29362864
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
Tacrolimus results in decreased expression of HMGCS2 mRNA
CTD
PMID:25270620
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression multiple interactions decreases expression
ISO EXP
Tacrolimus results in increased expression of HMOX1 mRNA; Tacrolimus results in increased expression of HMOX1 protein MK0626 inhibits the reaction [Tacrolimus results in decreased expression of HMOX1 protein]
CTD
PMID:23958496 PMID:24959755 PMID:26260164 PMID:29362864
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf1b
HNF1 homeobox B
decreases expression
ISO
Tacrolimus results in decreased expression of HNF1B mRNA
CTD
PMID:22416070
NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
G
Hsdl2
hydroxysteroid dehydrogenase like 2
decreases expression
ISO
Tacrolimus results in decreased expression of HSDL2 mRNA
CTD
PMID:25270620
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Tacrolimus results in increased expression of HSPA5 mRNA
CTD
PMID:25270620
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions increases expression
EXP
Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein] Tacrolimus results in increased expression of HSPA8 protein
CTD
PMID:15081597
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Htr1a
5-hydroxytryptamine receptor 1A
decreases expression
ISO
Tacrolimus results in decreased expression of HTR1A protein
CTD
PMID:27606422
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
decreases expression
ISO
Tacrolimus results in decreased expression of HTR1B protein
CTD
PMID:27606422
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Icam1
intercellular adhesion molecule 1
decreases expression increases expression
EXP ISO
Tacrolimus results in decreased expression of ICAM1; Tacrolimus results in decreased expression of ICAM1 protein Tacrolimus results in increased expression of ICAM1 mRNA
CTD
PMID:9794552 PMID:10385251 PMID:23958496
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
Tacrolimus results in increased expression of ID1 mRNA
CTD
PMID:25270620 PMID:29362864
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
Tacrolimus results in increased expression of ID2 mRNA
CTD
PMID:25270620
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
Tacrolimus results in increased expression of ID3 mRNA
CTD
PMID:29362864
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Id4
inhibitor of DNA binding 4
increases expression
ISO
Tacrolimus results in increased expression of ID4 mRNA
CTD
PMID:25270620
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Tacrolimus results in decreased expression of IDI1 mRNA
CTD
PMID:25270620
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
increases expression
ISO
Tacrolimus results in increased expression of IFI27L2A mRNA
CTD
PMID:29362864
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
G
Ifng
interferon gamma
multiple interactions decreases secretion decreases expression
ISO EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA] Tacrolimus results in decreased secretion of IFNG protein Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein] Tacrolimus results in decreased expression of IFNG mRNA; Tacrolimus results in decreased expression of IFNG protein [Tacrolimus co-treated with TAK 779] results in decreased expression of IFNG protein
CTD
PMID:1371491 PMID:8986461 PMID:10205001 PMID:11407316 PMID:11692113 PMID:16368244 PMID:20967261 PMID:21515370 PMID:24603311 PMID:29594315 More...
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
increases response to substance
EXP
IGF1 protein results in increased susceptibility to Tacrolimus
CTD
PMID:12826230
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp1
insulin-like growth factor binding protein 1
decreases expression increases expression
EXP
Tacrolimus results in decreased expression of IGFBP1 mRNA Tacrolimus results in increased expression of IGFBP1 mRNA
CTD
PMID:21865292
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
EXP
Tacrolimus results in increased expression of IGFBP5 mRNA
CTD
PMID:21865292
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il12b
interleukin 12B
multiple interactions
ISO
Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
CTD
PMID:36416909
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il15ra
interleukin 15 receptor subunit alpha
increases expression
ISO
Tacrolimus results in increased expression of IL15RA mRNA
CTD
PMID:23958496
NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
G
Il17ra
interleukin 17 receptor A
increases expression
ISO
Tacrolimus results in increased expression of IL17RA mRNA
CTD
PMID:23958496
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il1b
interleukin 1 beta
increases expression
ISO
Tacrolimus results in increased expression of IL1B mRNA
CTD
PMID:29594315
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
ISO
Tacrolimus results in increased expression of IL1RN mRNA
CTD
PMID:23958496
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
multiple interactions decreases expression
ISO EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [Zinc Sulfate inhibits the reaction [Mitogens results in increased expression of IL2 mRNA]] Tacrolimus results in decreased expression of IL2 protein Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]; Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]] Tacrolimus results in decreased expression of IL2 mRNA Tacrolimus results in decreased expression of IL2 mRNA; Tacrolimus results in decreased expression of IL2 protein
CTD
PMID:1371491 PMID:1614535 PMID:1701765 PMID:1705513 PMID:8986461 PMID:11407316 PMID:12126653 PMID:16055081 PMID:24603311 PMID:25770929 PMID:29594315 More...
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Tacrolimus results in increased expression of IL23A mRNA
CTD
PMID:25270620
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il2ra
interleukin 2 receptor subunit alpha
decreases expression
ISO
Tacrolimus results in decreased expression of IL2RA protein
CTD
PMID:1701765
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il3
interleukin 3
decreases expression multiple interactions
ISO
Tacrolimus results in decreased expression of IL3 protein Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
CTD
PMID:1376361 PMID:11407316
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4
interleukin 4
multiple interactions decreases expression
ISO EXP
Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein] Tacrolimus inhibits the reaction [bisphenol A promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [bisphenol A results in increased expression of IL4 protein]; Tacrolimus inhibits the reaction [nonylphenol promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [nonylphenol results in increased expression of IL4 protein] Tacrolimus results in decreased expression of IL4 protein Tacrolimus results in decreased expression of IL4 mRNA; Tacrolimus results in decreased expression of IL4 protein
CTD
PMID:1371491 PMID:10685002 PMID:11407316 PMID:12709020 PMID:16368244
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
multiple interactions decreases expression
ISO
Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] Tacrolimus results in decreased expression of IL5 mRNA; Tacrolimus results in decreased expression of IL5 protein
CTD
PMID:1371491 PMID:7540862 PMID:11407316 PMID:15948978
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
multiple interactions decreases expression increases expression
EXP ISO
[Tacrolimus co-treated with quinapril] results in decreased expression of IL6 protein; [Tacrolimus co-treated with quinapril] results in increased expression of IL6 protein; [Tacrolimus co-treated with Valsartan] results in decreased expression of IL6 protein; [Tacrolimus co-treated with Valsartan] results in increased expression of IL6 protein Tacrolimus results in decreased expression of IL6 protein Tacrolimus results in increased expression of IL6 protein parthenolide inhibits the reaction [Tacrolimus results in increased expression of IL6 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of IL6 mRNA]
CTD
PMID:16549154 PMID:23958496
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Imp4
IMP U3 small nucleolar ribonucleoprotein 4
decreases expression
ISO
Tacrolimus results in decreased expression of IMP4 mRNA
CTD
PMID:25270620
NCBI chr 9:36,654,127...36,659,265
Ensembl chr 9:36,654,401...36,660,075
G
Ino80e
INO80 complex subunit E
decreases expression
ISO
Tacrolimus results in decreased expression of INO80E mRNA
CTD
PMID:25270620
NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:181,461,408...181,472,469
G
Ins1
insulin 1
decreases expression multiple interactions
EXP
Tacrolimus results in decreased expression of INS1 protein MK0626 inhibits the reaction [Tacrolimus results in decreased expression of INS1 protein]
CTD
PMID:24959755
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
decreases expression
ISO
Tacrolimus results in decreased expression of INS protein
CTD
PMID:17391142
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Irak1
interleukin-1 receptor-associated kinase 1
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of IRAK1 protein
CTD
PMID:23958496
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Itgal
integrin subunit alpha L
decreases expression
EXP
Tacrolimus results in decreased expression of ITGAL
CTD
PMID:9794552
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Jak2
Janus kinase 2
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of JAK2 protein
CTD
PMID:23958496
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Tacrolimus results in decreased expression of JUN protein
CTD
PMID:9674596
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tacrolimus results in increased expression of JUNB mRNA
CTD
PMID:23958496
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kifap3
kinesin-associated protein 3
decreases expression
EXP
Tacrolimus results in decreased expression of KIFAP3 mRNA
CTD
PMID:21865292
NCBI chr13:76,127,702...76,264,654
Ensembl chr13:76,127,696...76,264,650
G
Kifc1
kinesin family member C1
decreases expression
EXP
Tacrolimus results in decreased expression of KIFC1 mRNA
CTD
PMID:21865292
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
G
Klf5
KLF transcription factor 5
increases expression
EXP
Tacrolimus results in increased expression of KLF5 mRNA
CTD
PMID:21865292
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Klf6
KLF transcription factor 6
increases expression
EXP
Tacrolimus results in increased expression of KLF6 mRNA
CTD
PMID:21865292
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
EXP
Tacrolimus results in increased expression of KLK1C10 mRNA
CTD
PMID:21865292
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Klk1c9
kallikrein 1-related peptidase C9
increases expression
EXP
Tacrolimus results in increased expression of KLK1C9 mRNA
CTD
PMID:21865292
NCBI chr 1:94,597,359...94,601,245
Ensembl chr 1:94,597,359...94,601,245
G
Kras
KRAS proto-oncogene, GTPase
increases expression
ISO
Tacrolimus results in increased expression of KRAS mRNA
CTD
PMID:25270620
NCBI chr 4:178,185,418...178,218,484
G
Krt20
keratin 20
increases expression
ISO
Tacrolimus results in increased expression of KRT20 mRNA
CTD
PMID:29362864
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
G
Lamc2
laminin subunit gamma 2
increases expression
EXP
Tacrolimus results in increased expression of LAMC2 mRNA
CTD
PMID:21865292
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Tacrolimus results in increased expression of LBP mRNA
CTD
PMID:21865292
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lcn2
lipocalin 2
increases expression
EXP ISO
Tacrolimus results in increased expression of LCN2 mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lias
lipoic acid synthetase
decreases expression
ISO
Tacrolimus results in decreased expression of LIAS mRNA
CTD
PMID:21621594
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Tacrolimus results in increased expression of LIF mRNA
CTD
PMID:23958496
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Limk1
LIM domain kinase 1
increases expression
ISO
Tacrolimus results in increased expression of LIMK1 mRNA
CTD
PMID:29380240
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
G
Llgl1
LLGL scribble cell polarity complex component 1
increases expression
ISO
Tacrolimus results in increased expression of LLGL1 mRNA
CTD
PMID:29380240
NCBI chr10:45,379,423...45,394,096
Ensembl chr10:45,379,515...45,394,094
G
Lta
lymphotoxin alpha
multiple interactions
ISO
Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of LTA protein]
CTD
PMID:1371491
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Ltf
lactotransferrin
increases expression
ISO
Tacrolimus results in increased expression of LTF mRNA
CTD
PMID:21621594
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Ly86
lymphocyte antigen 86
increases expression
ISO
Tacrolimus results in increased expression of LY86 mRNA
CTD
PMID:29362864
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
decreases expression
ISO
Tacrolimus results in decreased expression of LYVE1 mRNA
CTD
PMID:25270620
NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Tacrolimus results in increased expression of MAFF mRNA
CTD
PMID:23958496
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafk
MAF bZIP transcription factor K
increases expression
ISO
Tacrolimus results in increased expression of MAFK mRNA
CTD
PMID:23958496
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
Tacrolimus results in increased expression of MANF mRNA
CTD
PMID:25270620
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Map3k7
mitogen activated protein kinase kinase kinase 7
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of MAP3K7 protein
CTD
PMID:23958496
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk8
mitogen-activated protein kinase 8
decreases activity multiple interactions
EXP
Tacrolimus results in decreased activity of MAPK8 protein Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein]
CTD
PMID:12892836
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
ISO
Tacrolimus results in decreased expression of MBNL2 mRNA
CTD
PMID:25270620
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
Tacrolimus results in decreased expression of MCAM mRNA
CTD
PMID:25270620
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcrs1
microspherule protein 1
decreases expression
ISO
Tacrolimus results in decreased expression of MCRS1 mRNA
CTD
PMID:25270620
NCBI chr 7:130,383,853...130,392,667
Ensembl chr 7:130,383,853...130,392,685
G
Mettl1
methyltransferase 1, tRNA methylguanosine
increases expression
ISO
Tacrolimus results in increased expression of METTL1 mRNA
CTD
PMID:25270620
NCBI chr 7:62,864,860...62,869,202
Ensembl chr 7:62,864,853...62,869,202
G
Mfsd1
major facilitator superfamily domain containing 1
increases expression
ISO
Tacrolimus results in increased expression of MFSD1 mRNA
CTD
PMID:25270620
NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:151,846,146...151,867,045
G
Mgll
monoglyceride lipase
decreases expression
ISO
Tacrolimus results in decreased expression of MGLL mRNA
CTD
PMID:25270620
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mir146a
microRNA 146a
increases expression
ISO
Tacrolimus results in increased expression of MIR146 mRNA
CTD
PMID:29362864
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir146b
microRNA 146b
increases expression
ISO
Tacrolimus results in increased expression of MIR146B mRNA
CTD
PMID:29362864
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
G
Mir193a
microRNA 193a
decreases expression
ISO
Tacrolimus results in decreased expression of MIR193A mRNA
CTD
PMID:29362864
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir200b
microRNA 200b
decreases expression
ISO
Tacrolimus results in decreased expression of MIR200B mRNA
CTD
PMID:29362864
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
G
Mir21
microRNA 21
increases expression
ISO
Tacrolimus results in increased expression of MIR21A mRNA
CTD
PMID:29362864
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir214
microRNA 214
increases expression
ISO
Tacrolimus results in increased expression of MIR214 mRNA
CTD
PMID:29362864
NCBI chr13:74,588,374...74,588,481
Ensembl chr13:74,588,372...74,588,481
G
Mir34b
microRNA 34b
increases expression
ISO
Tacrolimus results in increased expression of MIR34B mRNA
CTD
PMID:29362864
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
G
Mir551b
microRNA 551b
decreases expression
ISO
Tacrolimus results in decreased expression of MIR551B mRNA
CTD
PMID:29362864
NCBI chr 2:113,989,203...113,989,300
Ensembl chr 2:113,989,203...113,989,300
G
Mob4
MOB family member 4, phocein
increases expression
ISO
Tacrolimus results in increased expression of MOB4 mRNA
CTD
PMID:25270620
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Mpo
myeloperoxidase
multiple interactions decreases expression
EXP
Tacrolimus inhibits the reaction [Indomethacin results in increased activity of MPO protein] Tacrolimus results in decreased expression of MPO protein
CTD
PMID:9655420 PMID:17202747
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mrm3
mitochondrial rRNA methyltransferase 3
decreases expression
ISO
Tacrolimus results in decreased expression of MRM3 mRNA
CTD
PMID:25270620
NCBI chr10:61,095,920...61,125,421
Ensembl chr10:61,095,952...61,102,630
G
Ms4a6a
membrane spanning 4-domains A6A
increases expression
ISO
Tacrolimus results in increased expression of MS4A6C mRNA
CTD
PMID:29362864
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
G
Msln
mesothelin
increases expression
ISO
Tacrolimus results in increased expression of MSLN mRNA
CTD
PMID:29362864
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP ISO
Tacrolimus results in increased expression of MYC mRNA
CTD
PMID:21865292 PMID:23958496
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Naaa
N-acylethanolamine acid amidase
increases expression
ISO
Tacrolimus results in increased expression of NAAA mRNA
CTD
PMID:29362864
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
G
Nckap1l
NCK associated protein 1 like
increases expression
ISO
Tacrolimus results in increased expression of NCKAP1L mRNA
CTD
PMID:29362864
NCBI chr 7:134,577,470...134,622,928
Ensembl chr 7:134,577,482...134,622,934
G
Ncr3
natural cytotoxicity triggering receptor 3
increases expression
ISO
Tacrolimus results in increased expression of NCR3
CTD
PMID:20736080
NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
Tacrolimus results in increased expression of NDRG1 mRNA
CTD
PMID:25270620
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nfatc3
nuclear factor of activated T-cells 3
multiple interactions
ISO
Tacrolimus inhibits the reaction [bisphenol A promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [nonylphenol promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [Thapsigargin affects the localization of and results in increased activity of NFATC3 protein]
CTD
PMID:10339586 PMID:12709020
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
G
Nfatc4
nuclear factor of activated T-cells 4
multiple interactions
ISO EXP
Tacrolimus inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased localization of NFATC4 protein]; Tacrolimus inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein]
CTD
PMID:16055480
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
Tacrolimus results in increased expression of NFE2L2 protein
CTD
PMID:23958496
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions increases expression
ISO
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFKB1 protein] Tacrolimus results in increased expression of NFKB1 mRNA
CTD
PMID:18172213 PMID:18172886 PMID:23958496
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
increases expression
ISO
Tacrolimus results in increased expression of NFKB2 mRNA
CTD
PMID:23958496
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
decreases degradation multiple interactions increases phosphorylation
ISO
Tacrolimus results in decreased degradation of NFKBIA protein ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased phosphorylation of NFKBIA protein]
CTD
PMID:16181452 PMID:23958496
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbib
NFKB inhibitor beta
multiple interactions
ISO
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NFKBIB protein]
CTD
PMID:18172213 PMID:18172886
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
Tacrolimus results in increased expression of NFKBIE mRNA
CTD
PMID:23958496
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Ngf
nerve growth factor
multiple interactions
EXP
NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 mRNA]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 protein]
CTD
PMID:17385075 PMID:23825664
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nol8
nucleolar protein 8
increases expression
ISO
Tacrolimus results in increased expression of NOL8 mRNA
CTD
PMID:25270620
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
G
Nos1
nitric oxide synthase 1
multiple interactions
EXP
Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS1 protein]
CTD
PMID:20149694
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Tacrolimus inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS2 protein]; Tacrolimus inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]
CTD
PMID:12144947 PMID:17202747 PMID:20149694 PMID:27246103
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
increases expression decreases activity decreases expression
ISO EXP
Tacrolimus results in increased expression of NOS3 mRNA Tacrolimus results in decreased activity of NOS3 protein Tacrolimus results in decreased expression of NOS3 mRNA
CTD
PMID:9931093 PMID:12352326
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
increases expression
EXP
Tacrolimus results in increased expression of NOX1 mRNA
CTD
PMID:17085464
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nppa
natriuretic peptide A
multiple interactions
ISO
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPA mRNA]
CTD
PMID:15939815
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
multiple interactions
ISO
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPB mRNA]
CTD
PMID:15939815
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Npr1
natriuretic peptide receptor 1
multiple interactions
ISO
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]; Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPA mRNA]; Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPB mRNA]
CTD
PMID:15939815
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions increases activity
ISO
Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein]; Tacrolimus promotes the reaction [Dexamethasone binds to NR3C1 protein]; Tacrolimus promotes the reaction [NR3C1 protein binds to PPP5C protein] Tacrolimus results in increased activity of NR3C1 protein
CTD
PMID:15697228
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Ogn
osteoglycin
increases expression
EXP ISO
Tacrolimus results in increased expression of OGN mRNA
CTD
PMID:21865292 PMID:29362864
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
G
Olfml3
olfactomedin-like 3
increases expression
ISO
Tacrolimus results in increased expression of OLFML3 mRNA
CTD
PMID:29362864
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
G
Panx1
Pannexin 1
increases expression
ISO
Tacrolimus results in increased expression of PANX1 mRNA
CTD
PMID:29362864
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
G
Pbk
PDZ binding kinase
increases expression
ISO
Tacrolimus results in increased expression of PBK mRNA
CTD
PMID:29362864
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcbp4
poly(rC) binding protein 4
decreases expression
ISO
Tacrolimus results in decreased expression of PCBP4 mRNA
CTD
PMID:25270620
NCBI chr 8:107,092,688...107,103,276
Ensembl chr 8:107,093,013...107,103,276
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]]
CTD
PMID:25770929
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcolce
procollagen C-endopeptidase enhancer
decreases expression
ISO
Tacrolimus results in decreased expression of PCOLCE mRNA
CTD
PMID:25270620
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
Pdcd2
programmed cell death 2
increases expression
ISO
Tacrolimus results in increased expression of PDCD2 mRNA
CTD
PMID:25270620
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
G
Pdgfra
platelet derived growth factor receptor alpha
increases expression
ISO
Tacrolimus results in increased expression of PDGFRA mRNA
CTD
PMID:29362864
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
ISO
Tacrolimus results in increased expression of PDIA4 mRNA
CTD
PMID:25270620
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia6
protein disulfide isomerase family A, member 6
increases expression
ISO
Tacrolimus results in increased expression of PDIA6 mRNA
CTD
PMID:25270620
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Phlda1
pleckstrin homology-like domain, family A, member 1
increases expression
ISO
Tacrolimus results in increased expression of PHLDA1 mRNA
CTD
PMID:23958496
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Tacrolimus results in increased expression of PID1 mRNA
CTD
PMID:29362864
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pink1
PTEN induced kinase 1
multiple interactions
ISO
PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]
CTD
PMID:19492085
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
ISO
Tacrolimus results in increased expression of PKMYT1 mRNA
CTD
PMID:29362864
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Pkp4
plakophilin 4
decreases expression
EXP
Tacrolimus results in decreased expression of PKP4 mRNA
CTD
PMID:21865292
NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
ISO
Tacrolimus results in increased expression of PLA2G12A mRNA
CTD
PMID:25270620
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Plat
plasminogen activator, tissue type
decreases expression
ISO
Tacrolimus results in decreased expression of PLAT mRNA
CTD
PMID:25270620
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plbd2
phospholipase B domain containing 2
decreases expression
ISO
Tacrolimus results in decreased expression of PLBD2 mRNA
CTD
PMID:25270620
NCBI chr12:36,062,802...36,081,984
Ensembl chr12:36,062,802...36,081,983
G
Por
cytochrome p450 oxidoreductase
affects response to substance
ISO
POR polymorphism affects the susceptibility to Tacrolimus
CTD
PMID:24113216
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Ppara
peroxisome proliferator activated receptor alpha
affects response to substance
ISO
PPARA polymorphism affects the susceptibility to Tacrolimus
CTD
PMID:24113216
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
[Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein
CTD
PMID:17016853
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppl
periplakin
increases expression
EXP
Tacrolimus results in increased expression of PPL mRNA
CTD
PMID:21865292
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
Tacrolimus results in increased expression of PPP1R15A mRNA
CTD
PMID:23958496
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
multiple interactions decreases activity
ISO
[Tacrolimus results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin
CTD
PMID:10898953 PMID:19553475
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp5c
protein phosphatase 5, catalytic subunit
multiple interactions
ISO
Tacrolimus promotes the reaction [NR3C1 protein binds to PPP5C protein]
CTD
PMID:15697228
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
G
Prcp
prolylcarboxypeptidase
increases expression
EXP
Tacrolimus results in increased expression of PRCP mRNA
CTD
PMID:21865292
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
G
Prlr
prolactin receptor
decreases expression
EXP
Tacrolimus results in decreased expression of PRLR mRNA
CTD
PMID:21865292
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Psmb10
proteasome 20S subunit beta 10
increases expression
ISO
Tacrolimus results in increased expression of PSMB10 mRNA
CTD
PMID:29362864
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
ISO
Tacrolimus inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] Tacrolimus results in increased expression of PTGS2 mRNA
CTD
PMID:12493747 PMID:23958496
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
decreases activity
ISO
Tacrolimus results in decreased activity of PTPN5 protein
CTD
PMID:17360923
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
increases expression
EXP
Tacrolimus results in increased expression of PTPRZ1 mRNA
CTD
PMID:21865292
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Rab4a
RAB4A, member RAS oncogene family
increases expression
ISO
Tacrolimus results in increased expression of RAB4A mRNA
CTD
PMID:29380240
NCBI chr19:51,795,613...51,822,706
Ensembl chr19:51,795,613...51,822,703
G
Rac1
Rac family small GTPase 1
increases expression
EXP
Tacrolimus results in increased expression of RAC1 mRNA
CTD
PMID:17085464
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Ramp1
receptor activity modifying protein 1
increases expression
ISO
Tacrolimus results in increased expression of RAMP1 mRNA
CTD
PMID:29362864
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
G
Rcc1
regulator of chromosome condensation 1
decreases expression
ISO
Tacrolimus results in decreased expression of RCC1 mRNA
CTD
PMID:25270620
NCBI chr 5:144,526,025...144,544,445
Ensembl chr 5:144,526,025...144,544,577
G
Rcor2
REST corepressor 2
decreases expression
ISO
Tacrolimus results in decreased expression of RCOR2 mRNA
CTD
PMID:25270620
NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838
G
Rel
REL proto-oncogene, NF-kB subunit
multiple interactions
ISO
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of REL protein]
CTD
PMID:18172213
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Tacrolimus co-treated with Thapsigargin] affects the localization of and results in increased activity of RELA protein; Tacrolimus affects the localization of and results in increased activity of RELA protein; Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of RELA protein]; Tacrolimus results in increased phosphorylation of and affects the localization of RELA protein
CTD
PMID:10339586 PMID:18172886 PMID:23958496
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
Tacrolimus results in increased expression of RELB mRNA
CTD
PMID:23958496
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Ren
renin
multiple interactions decreases activity increases expression
EXP
nilvadipine inhibits the reaction [Tacrolimus results in increased expression of REN protein] Tacrolimus results in decreased activity of REN protein Tacrolimus results in increased expression of REN mRNA; Tacrolimus results in increased expression of REN protein
CTD
PMID:7509514 PMID:7532090 PMID:7533848 PMID:12469222 PMID:21865292
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Renbp
renin binding protein
increases expression
ISO
Tacrolimus results in increased expression of RENBP mRNA
CTD
PMID:25270620
NCBI chr X:151,661,463...151,670,538
Ensembl chr X:151,661,458...151,670,516
G
Rgn
regucalcin
decreases expression
EXP
Tacrolimus results in decreased expression of RGN mRNA
CTD
PMID:21865292
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Tacrolimus results in increased expression of RGS16 mRNA
CTD
PMID:29362864
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhebl1
RHEB like 1
increases expression
ISO
Tacrolimus results in increased expression of RHEBL1 mRNA
CTD
PMID:23958496
NCBI chr 7:130,026,255...130,031,127
Ensembl chr 7:130,026,341...130,030,248
G
Rhou
ras homolog family member U
increases expression
ISO
Tacrolimus results in increased expression of RHOU mRNA
CTD
PMID:29362864
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
G
Rnase2
ribonuclease A family member 2
increases expression
ISO
Tacrolimus results in increased expression of RNASE2A mRNA
CTD
PMID:29362864
NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479
G
Rnase3
ribonuclease A family member 3
increases expression
ISO
Tacrolimus results in increased expression of EAR1 mRNA
CTD
PMID:29362864
NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790
G
Rpn1
ribophorin I
increases expression
ISO
Tacrolimus results in increased expression of RPN1 mRNA
CTD
PMID:25270620
NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:120,543,667...120,565,069
G
Rps6
ribosomal protein S6
multiple interactions
ISO
Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]]
CTD
PMID:1614535
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rrp9
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein
decreases expression
ISO
Tacrolimus results in decreased expression of RRP9 mRNA
CTD
PMID:25270620
NCBI chr 8:107,116,411...107,126,123
Ensembl chr 8:107,117,471...107,126,123
G
Runx2
RUNX family transcription factor 2
decreases expression
EXP
Tacrolimus results in decreased expression of RUNX2 mRNA
CTD
PMID:15780950
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Ryr1
ryanodine receptor 1
multiple interactions
ISO
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RYR1 protein]
CTD
PMID:18172213 PMID:18172886
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
S100a6
S100 calcium binding protein A6
increases expression
ISO
Tacrolimus results in increased expression of S100A6 mRNA
CTD
PMID:29362864
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
Sct
secretin
increases expression
ISO
Tacrolimus results in increased expression of SCT mRNA
CTD
PMID:29362864
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
Tacrolimus results in increased expression of SDF2L1 mRNA
CTD
PMID:25270620
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Seh1l
SEH1-like nucleoporin
increases expression
ISO
Tacrolimus results in increased expression of SEH1L mRNA
CTD
PMID:25270620
NCBI chr18:61,346,986...61,369,987
G
Sele
selectin E
increases expression
EXP
Tacrolimus results in increased expression of SELE mRNA
CTD
PMID:21865292
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenos
selenoprotein S
increases expression
ISO
Tacrolimus results in increased expression of SELENOS mRNA
CTD
PMID:25270620
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
G
Serinc3
serine incorporator 3
decreases expression
ISO
Tacrolimus results in decreased expression of SERINC3 mRNA
CTD
PMID:21621594
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
G
Serp1
stress-associated endoplasmic reticulum protein 1
increases expression
ISO
Tacrolimus results in increased expression of SERP1 mRNA
CTD
PMID:25270620
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
G
Serpina3n
serpin family A member 3N
increases expression
EXP
Tacrolimus results in increased expression of SERPINA3N mRNA
CTD
PMID:21865292
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpinb9
serpin family B member 9
increases expression
ISO
Tacrolimus results in increased expression of SERPINB9 mRNA
CTD
PMID:23958496
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpine1
serpin family E member 1
increases expression multiple interactions
EXP
Tacrolimus results in increased expression of SERPINE1 mRNA Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of SERPINE1 protein]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 mRNA]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 protein]
CTD
PMID:9422427 PMID:14620542 PMID:21865292 PMID:23825664
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sgo1
shugoshin 1
increases expression
ISO
Tacrolimus results in increased expression of SGO1 mRNA
CTD
PMID:29362864
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
G
Shf
Src homology 2 domain containing F
decreases expression
ISO
Tacrolimus results in decreased expression of SHF mRNA
CTD
PMID:25270620
NCBI chr 3:109,296,517...109,316,315
Ensembl chr 3:109,296,784...109,316,328
G
Sla
src-like adaptor
increases expression
ISO
Tacrolimus results in increased expression of SLA mRNA
CTD
PMID:29362864
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Slc12a3
solute carrier family 12 member 3
affects response to substance increases phosphorylation decreases expression
ISO EXP
SLC12A3 protein affects the susceptibility to Tacrolimus Tacrolimus results in increased phosphorylation of SLC12A3 protein Tacrolimus results in decreased expression of SLC12A3 mRNA; Tacrolimus results in decreased expression of SLC12A3 protein
CTD
PMID:21865292 PMID:21963515
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc16a1
solute carrier family 16 member 1
decreases expression
EXP
Tacrolimus results in decreased expression of SLC16A1 mRNA
CTD
PMID:21865292
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc22a13
solute carrier family 22 member 13
decreases expression
EXP
Tacrolimus results in decreased expression of SLC22A13 mRNA
CTD
PMID:21865292
NCBI chr 8:118,922,367...118,934,020
Ensembl chr 8:118,922,367...118,953,635
G
Slc25a25
solute carrier family 25 member 25
decreases expression
EXP
Tacrolimus results in decreased expression of SLC25A25 mRNA
CTD
PMID:21865292
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
G
Slc34a2
solute carrier family 34 member 2
increases expression
EXP
Tacrolimus results in increased expression of SLC34A2 mRNA
CTD
PMID:21865292
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Smad3
SMAD family member 3
multiple interactions
EXP
Tacrolimus inhibits the reaction [Paraquat results in increased expression of and results in increased secretion of SMAD3 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of SMAD3 mRNA]
CTD
PMID:33000210
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smad7
SMAD family member 7
multiple interactions
ISO EXP
Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]; Tacrolimus inhibits the reaction [SMAD7 protein binds to SMURF1 protein] Tacrolimus promotes the reaction [Paraquat results in increased expression of and results in increased secretion of SMAD7 protein]; Tacrolimus promotes the reaction [Paraquat results in increased expression of SMAD7 mRNA]
CTD
PMID:16720724 PMID:33000210
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smim14
small integral membrane protein 14
increases expression
ISO
Tacrolimus results in increased expression of SMIM14 mRNA
CTD
PMID:25270620
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
G
Smurf1
SMAD specific E3 ubiquitin protein ligase 1
multiple interactions
ISO
Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]; Tacrolimus inhibits the reaction [SMAD7 protein binds to SMURF1 protein]
CTD
PMID:16720724
NCBI chr12:9,635,009...9,726,520
Ensembl chr12:9,635,025...9,726,519
G
Snai1
snail family transcriptional repressor 1
increases expression multiple interactions
ISO
Tacrolimus results in increased expression of SNAI1 protein [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
CTD
PMID:22416070
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
Tacrolimus results in increased expression of SNAI2 mRNA
CTD
PMID:22416070
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Sod2
superoxide dismutase 2
increases response to substance multiple interactions decreases expression
ISO EXP
SOD2 protein results in increased susceptibility to Tacrolimus MK0626 inhibits the reaction [Tacrolimus results in decreased expression of SOD2 protein]
CTD
PMID:14675044 PMID:24959755
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
Tacrolimus results in increased expression of SOX9 mRNA
CTD
PMID:29362864
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp7
Sp7 transcription factor
decreases expression
EXP
Tacrolimus results in decreased expression of SP7 mRNA
CTD
PMID:15780950
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
G
Spaca7
sperm acrosome associated 7
increases expression
ISO
Tacrolimus results in increased expression of SPACA7 mRNA
CTD
PMID:29362864
NCBI chr16:76,928,611...76,955,547
Ensembl chr16:76,928,581...76,955,543
G
Spcs2
signal peptidase complex subunit 2
increases expression
ISO
Tacrolimus results in increased expression of SPCS2 mRNA
CTD
PMID:25270620
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
G
Sphk2
sphingosine kinase 2
decreases expression
ISO
Tacrolimus results in decreased expression of SPHK2 mRNA
CTD
PMID:25270620
NCBI chr 1:96,180,872...96,188,592
Ensembl chr 1:96,180,887...96,188,391
G
Spic
Spi-C transcription factor
increases expression
ISO
Tacrolimus results in increased expression of SPIC mRNA
CTD
PMID:29362864
NCBI chr 7:23,069,815...23,077,517
Ensembl chr 7:23,069,821...23,077,548
G
Spp1
secreted phosphoprotein 1
increases expression
EXP
Tacrolimus results in increased expression of SPP1 mRNA
CTD
PMID:12472797 PMID:21865292
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sqor
sulfide quinone oxidoreductase
decreases expression
ISO
Tacrolimus results in decreased expression of SQOR mRNA
CTD
PMID:25270620
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Ssr3
signal sequence receptor subunit 3
increases expression
ISO
Tacrolimus results in increased expression of SSR3 mRNA
CTD
PMID:25270620
NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132
G
Stard4
StAR-related lipid transfer domain containing 4
decreases expression
ISO
Tacrolimus results in decreased expression of STARD4 mRNA
CTD
PMID:25270620
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stat3
signal transducer and activator of transcription 3
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of STAT3 protein
CTD
PMID:23958496
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tada3
transcriptional adaptor 3
decreases expression
ISO
Tacrolimus results in decreased expression of TADA3 mRNA
CTD
PMID:25270620
NCBI chr 4:146,510,213...146,521,975
Ensembl chr 4:146,510,246...146,521,590
G
Tamalin
trafficking regulator and scaffold protein tamalin
increases expression
ISO
Tacrolimus results in increased expression of TAMALIN mRNA
CTD
PMID:25270620
NCBI chr 7:132,338,900...132,359,519
Ensembl chr 7:132,338,900...132,346,666
G
Tatdn1
TatD DNase domain containing 1
increases expression
ISO
Tacrolimus results in increased expression of TATDN1 mRNA
CTD
PMID:25270620
NCBI chr 7:90,449,979...90,481,000
Ensembl chr 7:90,441,079...90,481,133
G
Tekt1
tektin 1
increases expression
EXP
Tacrolimus results in increased expression of TEKT1 mRNA
CTD
PMID:21865292
NCBI chr10:56,952,164...56,980,572
Ensembl chr10:56,952,167...56,980,572
G
Tfeb
transcription factor EB
multiple interactions
ISO
[Cyclosporine co-treated with Tacrolimus] inhibits the reaction [4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole affects the localization of TFEB protein]
CTD
PMID:29650965
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Tfrc
transferrin receptor
decreases expression
ISO
Tacrolimus results in decreased expression of TFRC protein
CTD
PMID:1701765
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression decreases expression
ISO EXP
Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 mRNA] Tacrolimus results in increased expression of TGFB1 mRNA; Tacrolimus results in increased expression of TGFB1 protein [Tacrolimus co-treated with Quinapril] results in increased expression of TGFB1 protein; [Tacrolimus co-treated with Valsartan] results in increased expression of TGFB1 protein; pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of TGFB1 mRNA]; Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 protein]; Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of TGFB1 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of and results in increased secretion of TGFB1 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Valsartan inhibits the reaction [Tacrolimus results in increased expression of TGFB1 protein] Tacrolimus results in decreased expression of TGFB1 mRNA
CTD
PMID:9422427 PMID:11091246 PMID:12352326 PMID:12472797 PMID:14620542 PMID:15854665 PMID:16549154 PMID:16980036 PMID:17085464 PMID:17703430 PMID:18342291 PMID:33000210 PMID:33516819 More...
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbi
transforming growth factor, beta induced
increases expression
ISO
Tacrolimus results in increased expression of TGFBI mRNA
CTD
PMID:29362864
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
G
Tgfbr1
transforming growth factor, beta receptor 1
increases expression
EXP
Tacrolimus results in increased expression of TGFBR1 mRNA; Tacrolimus results in increased expression of TGFBR1 protein
CTD
PMID:16980036
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
increases expression
EXP
Tacrolimus results in increased expression of TGFBR2 mRNA; Tacrolimus results in increased expression of TGFBR2 protein
CTD
PMID:16980036
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Tgm1
transglutaminase 1
increases expression
EXP
Tacrolimus results in increased expression of TGM1 mRNA
CTD
PMID:21865292
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions increases expression decreases expression
EXP
pirfenidone promotes the reaction [Tacrolimus results in decreased expression of TIMP1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of TIMP1 mRNA]
CTD
PMID:11091246 PMID:12472797 PMID:15854665 PMID:21865292
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tlr2
toll-like receptor 2
increases expression
ISO
Tacrolimus results in increased expression of TLR2 mRNA
CTD
PMID:29362864
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmem202
transmembrane protein 202
decreases expression
ISO
Tacrolimus results in decreased expression of TMEM202 mRNA
CTD
PMID:25270620
NCBI chr 8:59,910,824...59,919,342
Ensembl chr 8:59,910,824...59,916,609
G
Tnf
tumor necrosis factor
multiple interactions decreases secretion decreases expression increases expression
ISO EXP
Tacrolimus inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with TNF protein] results in increased abundance of Superoxides]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Tacrolimus inhibits the reaction [Dieldrin results in increased expression of TNF mRNA]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of TNF protein]; Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Tacrolimus inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Tacrolimus results in decreased secretion of TNF protein Tacrolimus results in decreased expression of TNF mRNA; Tacrolimus results in decreased expression of TNF protein [Tacrolimus co-treated with Thapsigargin] results in increased expression of TNF protein Tacrolimus inhibits the reaction [Indomethacin results in increased expression of TNF mRNA] Tacrolimus results in increased expression of TNF mRNA
CTD
PMID:1371491 PMID:10339586 PMID:10385251 PMID:10685002 PMID:11121130 PMID:11169223 PMID:16181452 PMID:17202747 PMID:29362864 PMID:31068361 PMID:36416909 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip8l2
TNF alpha induced protein 8 like 2
increases expression
ISO
Tacrolimus results in increased expression of TNFAIP8L2 mRNA
CTD
PMID:29362864
NCBI chr 2:182,710,433...182,726,724
Ensembl chr 2:182,709,378...182,726,760
G
Tnfrsf11b
TNF receptor superfamily member 11B
decreases expression
EXP
Tacrolimus results in decreased expression of TNFRSF11B mRNA
CTD
PMID:21865292
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]
CTD
PMID:15207740 PMID:21869564
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
Tacrolimus results in increased expression of TNNT2 protein
CTD
PMID:12975596
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tp53
tumor protein p53
multiple interactions
EXP ISO
Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
CTD
PMID:10205001 PMID:12642403
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Tacrolimus results in increased expression of TRIB3 mRNA
CTD
PMID:23958496
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim2
tripartite motif-containing 2
decreases expression
ISO
Tacrolimus results in decreased expression of TRIM2 mRNA
CTD
PMID:25270620
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trip13
thyroid hormone receptor interactor 13
increases expression
ISO
Tacrolimus results in increased expression of TRIP13 mRNA
CTD
PMID:29362864
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
EXP
Tacrolimus results in decreased expression of TRPM6 mRNA
CTD
PMID:14978156
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions
ISO EXP
Tacrolimus results in increased phosphorylation of and affects the activity of TRPV1 protein Tacrolimus affects the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]
CTD
PMID:19553475
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
decreases expression
EXP
Tacrolimus results in decreased expression of TRPV5 mRNA; Tacrolimus results in decreased expression of TRPV5 protein
CTD
PMID:14978156
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
G
Txn1
thioredoxin 1
decreases expression
EXP
Tacrolimus results in decreased expression of TXN mRNA
CTD
PMID:17085464
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Ubd
ubiquitin D
increases expression
ISO
Tacrolimus results in increased expression of UBD mRNA
CTD
PMID:29362864
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Utf1
undifferentiated embryonic cell transcription factor 1
decreases expression
ISO
Tacrolimus results in decreased expression of UTF1 mRNA
CTD
PMID:25270620
NCBI chr 1:194,740,339...194,741,465
Ensembl chr 1:194,740,339...194,741,465
G
Vasn
vasorin
decreases expression
EXP
Tacrolimus results in decreased expression of VASN mRNA
CTD
PMID:17028423
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vasp
vasodilator-stimulated phosphoprotein
decreases expression
ISO
Tacrolimus results in decreased expression of VASP mRNA
CTD
PMID:29380240
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Tacrolimus results in increased expression of VCAM1 mRNA
CTD
PMID:23958496 PMID:29362864
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
increases expression
EXP
Tacrolimus results in increased expression of VCAN mRNA
CTD
PMID:21865292
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vegfa
vascular endothelial growth factor A
increases expression
EXP
Tacrolimus results in increased expression of VEGFA protein
CTD
PMID:17703430
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
increases expression
ISO
Tacrolimus results in increased expression of VIM protein
CTD
PMID:22416070 PMID:29362864
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wdfy4
WDFY family member 4
increases expression
ISO
Tacrolimus results in increased expression of WDFY4 mRNA
CTD
PMID:29362864
NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,221,719...8,450,491
G
Wdr31
WD repeat domain 31
decreases expression
ISO
Tacrolimus results in decreased expression of WDR31 mRNA
CTD
PMID:25270620
NCBI chr 5:75,897,074...75,917,461
Ensembl chr 5:75,898,353...75,917,417
G
Wdr54
WD repeat domain 54
decreases expression
ISO
Tacrolimus results in decreased expression of WDR54 mRNA
CTD
PMID:25270620
NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:115,654,968...115,661,562
G
Wdr73
WD repeat domain 73
decreases expression
ISO
Tacrolimus results in decreased expression of WDR73 mRNA
CTD
PMID:25270620
NCBI chr 1:134,860,329...134,868,475
Ensembl chr 1:134,860,180...134,868,479
G
Wfdc17
WAP four-disulfide core domain 17
increases expression
ISO
Tacrolimus results in increased expression of WFDC17 mRNA
CTD
PMID:29362864
NCBI chr10:68,561,954...68,562,801
Ensembl chr10:68,561,954...68,562,801
G
Wfdc18
WAP four-disulfide core domain 18
increases expression
ISO
Tacrolimus results in increased expression of WFDC18 mRNA
CTD
PMID:29362864
NCBI chr10:68,588,818...68,590,972
Ensembl chr10:68,588,818...68,589,671
G
Wnk3
WNK lysine deficient protein kinase 3
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of WNK3 protein
CTD
PMID:21963515
NCBI chr X:20,156,260...20,299,252
Ensembl chr X:20,157,041...20,296,821
G
Wnk4
WNK lysine deficient protein kinase 4
increases phosphorylation
ISO
Tacrolimus results in increased phosphorylation of WNK4 protein
CTD
PMID:21963515
NCBI chr10:86,202,552...86,219,655
Ensembl chr10:86,188,812...86,231,829
G
Xbp1
X-box binding protein 1
multiple interactions increases expression
ISO
Tacrolimus results in increased expression of and affects the localization of XBP1 protein modified form Tacrolimus results in increased expression of XBP1 mRNA
CTD
PMID:23958496 PMID:25270620
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xcl1
X-C motif chemokine ligand 1
increases expression
ISO
Tacrolimus results in increased expression of XCL1 mRNA
CTD
PMID:29362864
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
G
Zfyve16
zinc finger FYVE-type containing 16
increases expression
ISO
Tacrolimus results in increased expression of ZFYVE16 mRNA
CTD
PMID:25270620
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all